COMBINATION THERAPY FOR B-CELL LYMPHOMA COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY

Title:

COMBINATION THERAPY FOR B-CELL LYMPHOMA COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY

Document Type and Number:

Japanese Patent JP2010265318

Kind Code:

A

Abstract:

To provide a combined therapeutic method for B-cell lymphoma comprising administration of anti-CD20 antibodies with cytokines, radiotherapy, myeloablative therapy, or chemotherapy.

There is provided the treating method for recurrent B-cell lymphoma comprising administration of a therapeutically effective amount of anti-CD20 antibodies to a patient having recurrent B-cell lymphoma.

Inventors:

GRILLO-LOPEZ ANTONIO

Application Number:

JP2010185374A

Publication Date:

November 25, 2010

Filing Date:

August 20, 2010

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BIOGEN IDEC INC

International Classes:

A61K38/21; A61K38/00; A61K39/395; A61K51/00; A61K51/10; A61P35/00; A61P35/02; A61P35/04; C02F1/00; C07K16/00; C07K16/28

Domestic Patent References:

JPH05508630A	1993-12-02
JPH08503468A	1996-04-16

Foreign References:

WO1996018413A1

1996-06-20

Other References:

JPN6008057709; Ｒ．　Ｌ．　Ｗａｈｌ: Ｐｒｏｇ．　Ｐｒｏｃ．　Ａｍ．　Ｓｏｃ．　Ｃｌｉｎ．　Ｏｎｃｏｌ．Ｖｏｌ．１７, 199805, ４０ａ
JPN6008057707; Ｔ．　Ｄａｖｉｓ: ＢｌｏｏｄＶｏｌ．９０，　Ｎｏ．１０，　Ｓｕｐｐｌｅｍｅｎｔ　１（Ｐａｒｔ　１　ｏｆ　２）, 1997, ５０９ａ
JPN6008057706; Ｄａｖｉｄ　Ｇ．　Ｍａｌｏｎｅｙ: Ｊ．　Ｃｌｉｎ．　Ｏｎｃｏｌ．Ｖｏｌ．１５，　Ｎｏ．１０, 1997, ３２６６-３２７４
JPN6008057702; Ｓｕｓａｎ　Ｊ．　Ｋｎｏｘ: Ｃｌｉｎｉｃａｌ　Ｃａｎｃｅｒ　ＲｅｓｅａｒｃｈＶｏｌ．２, 1996, ４５７-４７０
JPN6008057698; Ｌ．　Ｅ．　Ｖａｎ　ｄｅｒ　Ｋｏｌｋ: Ｂｒｉｔｉｓｈ　Ｊｏｕｒｎａｌ　ｏｆ　ＨａｅｍａｔｏｌｏｇｙＶｏｌ．１０２，　Ｎｏ．１, 199807, ２４３
JPN6012067428; 木村郁郎他: '「ＶＩＩ　血液疾患治療薬＜リンパ系腫瘍＞　１７７．非ホジキンリンパ腫の薬物治療」' ＭｅｄｉｃｉｎａＶｏｌ．２４，Ｎｏ．１０，１９８７増刊号, 1987, ｐ．２１９４-２１９７

Attorney, Agent or Firm:

Hideto Asamura
Hajime Asamura
Naganuma Akio
Yukihiro Ikeda

Previous Patent: 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDRO...

Next Patent: PHARMACEUTICAL CARRIER DEVICE SUITABLE FOR DELIVERY OF PHARMACEUTICAL COMPOUND TO MUCOSAL SURFACE